Immediate Past Chairwoman

AZBio Board of Directors

Kristen Swingle

President & Chief Operating Officer, Critical Path Institute (C-Path)

Kristen Swingle was elected Chairwoman of  the AZBio Board of Directors in January 2018 and served as chair until December 2023.

Kristen serves as President and Chief Operating Officer of the Critical Path Institute (C-Path) .  Prior to joining C-Path in 2019, Kristen served as the VP of Stem Cell Operations at Cord Blood Registry where she was responsible for overseeing all operations at CBR’s laboratory in Tucson, Arizona, since 2007.

Kristen has over two decades’ worth of experience in the medical and molecular sciences industry with a strong background in product development and manufacturing, quality and regulatory affairs management, project and fiscal management, and team leadership.  As COO of C-Path, she is responsible for the daily operations of the organization and development and implementation of C-Path’s global strategy and goals.

Kristen holds a BS in Biology from Northern Arizona University and Master of Science (MS), Medical Sciences from Texas A&M University.

About C-Path

Founded in 2005, as a public-private partnership in response to the FDA’s Critical Path Initiative, Critical Path Institute® (C-Path) celebrates its 20th anniversary as a vital, independent, nonprofit. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.